The reverse tetracycline-controlled transactivator rtTA2s-S2 is toxic in mouse embryonic stem cells

Warning

This publication doesn't include Faculty of Medicine. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	BRYJA V. PACHERNÍK J. KUBALA L. HAMPL Aleš DVOŘÁK P.
Year of publication	2003
Type	Article in Periodical
Magazine / Source	Reproduction, nutrition, development
MU Faculty or unit	Faculty of Science
Citation
Field	Genetics and molecular biology
Keywords	stem cells
Description	The efficient and reversible control of transgene expression is a powerful tool for the correct manipulation of embryonic stem cells in both cell therapy and transgenesis. The aim of this work was to investigate the possibilities of recently developed reverse tetracycline-controlled transactivator rtTA2s-S2. We show that the rtTA2s-S2 is useful for transient inducible expression of genes in embryonic stem cells. However, we found that it was not possible to establish mouse embryonic stem cell lines stably expressing this transactivator. Using the viral IRES sequence which couples the expression of rtTA2s-S2 and neomycin phosphotransferase, we found that embryonic stem cells expressing rtTA2s-S2 are not capable of growing in the presence of G418. Our results indicate that this transactivator is toxic to ES cells and raise the need for the development of other strategies for stable and inducible expression of genes in ES cells.